Several treatments are now available to fight COVID-19 but tight timelines, unequal access and weakening effectiveness against new variants have limited their ability to blunt the worst of the pandemic.
May 1, 2022
0
39
Two senior senators—a Republican and a Democrat—unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs ...
Jul 23, 2019
0
0
Israeli pharmaceutical giant Teva vowed Saturday to defend itself after being accused of orchestrating price-fixing among drugmakers in a US antitrust lawsuit.
May 11, 2019
0
0
Eli Lilly is offering a half-price version of a top-selling insulin to ease the financial strain for some patients, but an advocacy group says much bigger changes are needed.
Mar 4, 2019
0
3
Several years ago, drug shortages became headline news when supplies of three different drugs used to treat childhood cancers were running low in major hospitals. Sometimes shortages like those are resolved before patients ...
Oct 24, 2018
0
1
(HealthDay)—Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.
Aug 9, 2018
0
0
Six generic drugmakers are asking a federal judge in Connecticut to dismiss a 40-state lawsuit accusing them of artificially inflating and manipulating prices to reduce competition for antibiotic and oral diabetes medication.
May 3, 2017
0
0
Drugmaker Pfizer said Monday that it will launch a less-expensive version of rival Johnson & Johnson's blockbuster immune disorder drug, Remicade.
Oct 18, 2016
0
0
Federal officials are encouraging generic drugmakers to develop painkillers that are harder to abuse, the latest in a string of steps designed to combat abuse of highly-addictive pain drugs like codeine and oxycodone.
Mar 24, 2016
0
7
Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington lawmakers.
Nov 20, 2014
0
0
